Sabra Healthcare REIT (SBRA) financial statements
Sabra Healthcare REIT reported revenue of $357M in fiscal 2025, up 3.6% a year over 9 years.
Net income was $156M.
The diluted share count rose 273% over the period (dilution).
Revenue and free cash flow
Fiscal years, $ billions.
Income statement
Fiscal years, from Sabra Healthcare REIT's 10-K filings with the SEC.
| Fiscal year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $261M | $26M | $70M | $128M | $156M | $156M | $187M | $236M | $285M | $357M |
| Selling, general and admin | $18M | $32M | $37M | $31M | $33M | $35M | $40M | $47M | $50M | $54M |
| Operating income | $255M | $9M | $21M | — | — | — | — | — | — | — |
| Interest expense | $65M | $88M | $147M | $127M | $100M | $99M | $105M | $113M | $115M | $112M |
| Pre-tax income | $71M | $159M | $288M | $79M | $156M | $81M | $22M | $19M | $128M | $153M |
| Income tax | $1M | $651,000 | $3M | $3M | $710,000 | $2M | $1M | $2M | $1M | $2M |
| Net income | $70M | $158M | $279M | $69M | $138M | -$113M | -$78M | $14M | $127M | $156M |
| EPS (diluted) | $0.92 | $1.40 | $1.51 | $0.37 | $0.67 | -$0.52 | -$0.34 | $0.06 | $0.54 | $0.64 |
| Diluted shares | 66M | 106M | 179M | 188M | 207M | 219M | 231M | 233M | 236M | 244M |
| Operating margin | 97.8% | 32.4% | 29.4% | — | — | — | — | — | — | — |
| Net margin | 27.0% | 599.3% | 397.9% | 53.9% | 88.7% | -72.8% | -41.6% | 5.8% | 44.5% | 43.6% |
Balance sheet
Fiscal years, from Sabra Healthcare REIT's 10-K filings with the SEC.
| Fiscal year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and short-term investments | $26M | $519M | $50M | $39M | $59M | $112M | $49M | $41M | $60M | $72M |
| Total assets | $2.3B | $7.0B | $6.7B | $6.1B | $6.0B | $6.0B | $5.7B | $5.4B | $5.3B | $5.5B |
| Total liabilities | $1.3B | $3.6B | $3.4B | $2.6B | $2.6B | $2.6B | $2.7B | $2.6B | $2.6B | $2.7B |
| Shareholders' equity | $1.0B | $3.4B | $3.3B | $3.5B | $3.4B | $3.4B | $3.1B | $2.8B | $2.7B | $2.8B |
| Net debt | -$26M | -$519M | -$50M | -$39M | -$59M | -$112M | -$49M | -$41M | -$60M | -$72M |
Cash flow
Fiscal years, from Sabra Healthcare REIT's 10-K filings with the SEC.
| Fiscal year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $176M | $136M | $361M | $372M | $355M | $356M | $316M | $301M | $311M | $349M |
| Stock-based compensation | $7M | $8M | $8M | $10M | $8M | $8M | $7M | $8M | $9M | $11M |
| Dividends paid | $119M | $182M | $325M | $335M | $278M | $263M | $277M | $277M | $280M | $289M |
| Dividends per share | $1.82 | $1.72 | $1.82 | $1.78 | $1.34 | $1.20 | $1.20 | $1.19 | $1.19 | $1.18 |
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for SBRA.
Open SBRA in InvestinglyQuestions
What was Sabra Healthcare REIT's revenue in 2025?
$357M in fiscal 2025, from its 10-K filing.
From Sabra Healthcare REIT's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.